JP2024528052A5 - - Google Patents
Info
- Publication number
- JP2024528052A5 JP2024528052A5 JP2024505255A JP2024505255A JP2024528052A5 JP 2024528052 A5 JP2024528052 A5 JP 2024528052A5 JP 2024505255 A JP2024505255 A JP 2024505255A JP 2024505255 A JP2024505255 A JP 2024505255A JP 2024528052 A5 JP2024528052 A5 JP 2024528052A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- cancer
- isolated nucleic
- molecule according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163227115P | 2021-07-29 | 2021-07-29 | |
| US63/227,115 | 2021-07-29 | ||
| US202263306862P | 2022-02-04 | 2022-02-04 | |
| US63/306,862 | 2022-02-04 | ||
| PCT/US2022/038640 WO2023009700A2 (en) | 2021-07-29 | 2022-07-28 | Car-expressing immune cells that specifically target mesothelin and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528052A JP2024528052A (ja) | 2024-07-26 |
| JP2024528052A5 true JP2024528052A5 (https=) | 2025-07-14 |
Family
ID=85088244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505255A Pending JP2024528052A (ja) | 2021-07-29 | 2022-07-28 | メソテリンを特異的に標的とするｃａｒ発現免疫細胞及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240374721A1 (https=) |
| EP (1) | EP4377355A4 (https=) |
| JP (1) | JP2024528052A (https=) |
| KR (1) | KR20240038723A (https=) |
| AU (1) | AU2022316980A1 (https=) |
| CA (1) | CA3227745A1 (https=) |
| CO (1) | CO2024001484A2 (https=) |
| IL (1) | IL309914A (https=) |
| MX (1) | MX2024001364A (https=) |
| TW (1) | TW202313979A (https=) |
| WO (1) | WO2023009700A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112771166B (zh) * | 2018-08-31 | 2025-03-04 | 诺伊尔免疫生物科技株式会社 | 表达car的t细胞和car表达载体 |
| AU2024263914A1 (en) | 2023-04-27 | 2025-12-04 | Takeda Pharmaceutical Company Limited | Method for expanding cd56+/cd3- cells |
| CN119101166A (zh) * | 2023-06-08 | 2024-12-10 | 博生吉医药科技(苏州)有限公司 | B7-H3嵌合抗原受体修饰的Vδ1 T细胞及其应用 |
| WO2025140683A1 (zh) * | 2023-12-29 | 2025-07-03 | 北京鼎成肽源生物技术有限公司 | 表达趋化因子10和白介素15的工程化免疫细胞 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9272002B2 (en) | 2011-10-28 | 2016-03-01 | The Trustees Of The University Of Pennsylvania | Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting |
| CN108728458B (zh) * | 2017-04-21 | 2021-11-16 | 上海恒润达生生物科技股份有限公司 | 靶向mesothelin的嵌合抗原受体并联合表达IL-15的方法和用途 |
| CN118948892A (zh) * | 2017-05-01 | 2024-11-15 | 朱诺治疗学股份有限公司 | 细胞疗法与免疫调节化合物的组合 |
| WO2018231759A1 (en) | 2017-06-12 | 2018-12-20 | Obsidian Therapeutics, Inc. | Pde5 compositions and methods for immunotherapy |
| WO2019124468A1 (ja) * | 2017-12-24 | 2019-06-27 | ノイルイミューン・バイオテック株式会社 | ヒトメソセリンを特異的に認識する細胞表面分子、ｉｌ－７、及びｃｃｌ１９を発現する免疫担当細胞 |
| US20200399383A1 (en) * | 2018-02-13 | 2020-12-24 | Novartis Ag | Chimeric antigen receptor therapy in combination with il-15r and il15 |
| CN112771166B (zh) | 2018-08-31 | 2025-03-04 | 诺伊尔免疫生物科技株式会社 | 表达car的t细胞和car表达载体 |
-
2022
- 2022-07-28 EP EP22850304.1A patent/EP4377355A4/en active Pending
- 2022-07-28 IL IL309914A patent/IL309914A/en unknown
- 2022-07-28 AU AU2022316980A patent/AU2022316980A1/en active Pending
- 2022-07-28 US US18/292,574 patent/US20240374721A1/en active Pending
- 2022-07-28 JP JP2024505255A patent/JP2024528052A/ja active Pending
- 2022-07-28 KR KR1020247003396A patent/KR20240038723A/ko active Pending
- 2022-07-28 WO PCT/US2022/038640 patent/WO2023009700A2/en not_active Ceased
- 2022-07-28 TW TW111128457A patent/TW202313979A/zh unknown
- 2022-07-28 CA CA3227745A patent/CA3227745A1/en active Pending
- 2022-07-28 MX MX2024001364A patent/MX2024001364A/es unknown
-
2024
- 2024-02-13 CO CONC2024/0001484A patent/CO2024001484A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024528052A5 (https=) | ||
| US20250034244A1 (en) | Bicistronic chimeric antigen receptors and their uses | |
| CN110872577B (zh) | 修饰的免疫细胞及其应用 | |
| You et al. | Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells | |
| JP6426713B2 (ja) | Ｇｐｃ３キメラ抗原受容体蛋白質をコードする核酸及びｇｐｃ３キメラ抗原受容体蛋白質を発現するｔリンパ球 | |
| US12492252B2 (en) | Anti-GPC3 antibody, anti-GPC3 chimeric antigen receptor and GPC3/CD3 bispecific antibody | |
| CN107312091A (zh) | 靶向人cd19抗原的人源化单克隆抗体 | |
| WO2017219936A1 (zh) | 一种高效稳定表达激活型抗体的car-t细胞及其用途 | |
| CN111944054B (zh) | 抗bcma的car及其表达载体和应用 | |
| WO2019085102A1 (zh) | Bcma特异性嵌合抗原受体t细胞及其应用 | |
| CN108367068A (zh) | 用于治疗白血病的抗-s100a8 | |
| WO2019184886A1 (zh) | 促进免疫细胞增殖的方法 | |
| CN114929863B (zh) | 共表达趋化因子受体的免疫效应细胞 | |
| JP2024528029A5 (https=) | ||
| CN115232217B (zh) | 一种SynNotch结构及其应用 | |
| Li et al. | Precision sniper for solid tumors: CAR-NK cell therapy | |
| CN117003897B (zh) | 靶向Claudin18.2的CAR-T细胞及其用途 | |
| CN117903317A (zh) | Trop2靶向的CAR分子、CAR-T细胞及其应用 | |
| CN113549157B (zh) | 双靶向嵌合抗原受体及其应用 | |
| CN114685675A (zh) | 双特异性抗体及其在治疗癌症中的用途 | |
| CN111499766B (zh) | 针对慢性淋巴细胞白血病的免疫效应细胞、其制备方法和应用 | |
| Esmaeilzadeh et al. | Chimeric antigen receptor (CAR) T Cell immunotherapy for solid tumors | |
| WO2022033483A1 (zh) | 多功能的免疫效应细胞及其应用 | |
| KR102809807B1 (ko) | 항-cldn18.2를 포함하는 키메릭 항원 수용체를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물 및 이의 제조 방법 | |
| CN120882754A (zh) | 用淋巴毒素β受体激动剂治疗癌症的方法 |